Alert: Regional Center has been Terminated. Termination Date: March 18, 2020.

MZH Capital Partners, Inc Rating

Profile Completion:Not Rated
Projects Completion:Not Rated
Site Activity:Not Rated
Knowledge:Not Rated
Experience:0 projects
I-924A Rating:Non-Transparent

CONTACT INFORMATION

MZH Capital Partners, Inc

STATES

New Jersey
  • [All State]
New York
  • [All State]
Pennsylvania
  • [All State]

LANGUAGES

English

0 followers

Last Update: May 20, 2020 03:22 AM

Regional Center was viewed 1826 times (total).

MZH Capital Partners, Inc

(2%)

MZH Capital Partners, Inc. was approved by USCIS on Nov 8, 2017. The regional center has approval to sponsor projects in the State of New Jersey, New York and Pennsylvania.

Is the Regional Center a Public Agency, Government Entity or a Public/Private Partnership (EDC/EDA) affiliated or associated with one?
No

Designation

Regional Center ID number
1533653487
Termination Date
2020-03-18

Regional Center EB-5 Quick Facts

Number of Approved I-526: N/A

Number of Approved I-829: N/A


Securities Disclaimer

This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. EB5Projects.com LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.